Kuros Biosciences AG (SWX: KURN)
Switzerland
· Delayed Price · Currency is CHF 21.50
+0.15 (0.70%)
Jan 3, 2025, 5:31 PM CET
Kuros Biosciences AG Revenue
Kuros Biosciences AG had revenue of 31.84M CHF in the half year ending June 30, 2024, with 205.43% growth. This brings the company's revenue in the last twelve months to 52.54M, up 157.23% year-over-year. In the year 2023, Kuros Biosciences AG had annual revenue of 33.56M with 86.61% growth.
Revenue (ttm)
52.54M
Revenue Growth
+157.23%
P/S Ratio
11.90
Revenue / Employee
495.68K
Employees
80
Market Cap
811.30M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Novartis AG | 42.18B |
| Lonza Group AG | 6.70B |
| Alcon | 8.25B |
| Galderma Group AG | 3.88B |
| Straumann Holding AG | 2.54B |
| Sonova Holding AG | 3.71B |
| Sandoz Group AG | 9.09B |